Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth

1 Jan 2018

Abstract excerpt

BACKGROUND: Gliomas are one of the most lethal cancers in the human central nervous system. Despite clinical treatment advancements, the prognosis of patients with glioma remains poor. KDM2B is a histone lysine demethylase, which has been observed in multiple tumors. But the concrete role of KDM2B in gliomas remains to be further illustrated. METHODS: The KDM2B expression in gliomas was detected with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Glioma Diagnosis and Treatment
Share to Kruppel-like factors research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29386904
DOI: 10.2147/ott.s149833

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KDM2B overexpression correlates with poor prognosis and regulates glioma cell growthPMID 29386904Read ↗

KDM1 is a novel therapeutic target for the treatment of gliomasSemantic proximity Read ↗

Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stabilitySemantic proximity Read ↗

PSMC2/E2F1 Axis Promotes the Development and Progression of GliomaSemantic proximity Read ↗

CADM2 inhibits human glioma proliferation, migration and invasionSemantic proximity Read ↗

Targeting glioma stem‐like cell survival and chemoresistance through inhibition of lysine‐specific histone demethylase KDM 2BSemantic proximity Read ↗

Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-MycSemantic proximity Read ↗

TMEM2 Combined with IDH and 1p19q in Refining Molecular Subtypes for Predicting Survival of Patients with Glioma.Semantic proximity Read ↗

Integrated Analysis Identifies MEOX2 as a Malignant Driver and Prognostic Biomarker in Brain GliomaSemantic proximity Read ↗

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-RadiotherapySemantic proximity Read ↗

Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomasSemantic proximity Read ↗

HMGN2 accelerates the proliferation and cell cycle progression of glioblastoma by regulating CDC20 expressionSemantic proximity Read ↗

RRM2 is a potential prognostic biomarker with functional significance in gliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.